• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化的 T 细胞与肿瘤相关巨噬细胞之间的动态相互作用驱动了前列腺肿瘤模型中巨噬细胞的重编程和促炎 T 细胞的迁移。

Dynamic reciprocal interactions between activated T cells and tumor associated macrophages drive macrophage reprogramming and proinflammatory T cell migration within prostate tumor models.

机构信息

Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.

出版信息

Sci Rep. 2024 Oct 16;14(1):24230. doi: 10.1038/s41598-024-75265-9.

DOI:10.1038/s41598-024-75265-9
PMID:39414902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11484957/
Abstract

Tumor-associated macrophages (TAMs) have been implicated as a tumor microenvironment (TME) cell population, which may be playing a vital role in the inhibition of effective T cell responses in the prostate TME. In this manuscript, we leverage a novel microscale cell culture platform, known as Stacks, to investigate mono-, co-, and tri-culture TME models comprised of prostate tumor cell lines, primary macrophages, and autologous T cells from patients with prostate cancer. Through multiplexed analysis of these multi-cellular prostate tumor models, we capture a dynamic interaction between primary TAMs and activated T cells that resulted in reciprocal proinflammatory activation of both cell populations upon interaction. These findings suggest that activated T cells are capable of reprogramming immunosuppressive TAMs in the context of prostate tumor models and that TAM reprogramming may play a key supportive role in restoring proinflammatory T cell tumor responses in the prostate TME.

摘要

肿瘤相关巨噬细胞(TAMs)被认为是肿瘤微环境(TME)中的一种细胞群体,它们可能在抑制前列腺 TME 中有效 T 细胞反应方面发挥着至关重要的作用。在本手稿中,我们利用一种新颖的微尺度细胞培养平台,即 Stacks,来研究由前列腺癌细胞系、原代巨噬细胞和来自前列腺癌患者的自体 T 细胞组成的单、共、三培养 TME 模型。通过对这些多细胞前列腺肿瘤模型进行多重分析,我们捕捉到了原代 TAMs 和活化 T 细胞之间的动态相互作用,导致相互作用时两个细胞群体的互惠性促炎激活。这些发现表明,活化的 T 细胞能够在前列腺肿瘤模型的背景下重新编程免疫抑制性 TAMs,并且 TAM 重编程可能在恢复前列腺 TME 中促炎 T 细胞肿瘤反应方面发挥关键的支持作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/e1ea56f8884e/41598_2024_75265_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/b7fe4269f3a3/41598_2024_75265_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/b2f897b522c8/41598_2024_75265_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/5be13c6cdb21/41598_2024_75265_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/073309a0acec/41598_2024_75265_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/0f5666bf5e7f/41598_2024_75265_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/c18d235b5500/41598_2024_75265_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/e1ea56f8884e/41598_2024_75265_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/b7fe4269f3a3/41598_2024_75265_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/b2f897b522c8/41598_2024_75265_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/5be13c6cdb21/41598_2024_75265_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/073309a0acec/41598_2024_75265_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/0f5666bf5e7f/41598_2024_75265_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/c18d235b5500/41598_2024_75265_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11484957/e1ea56f8884e/41598_2024_75265_Fig7_HTML.jpg

相似文献

1
Dynamic reciprocal interactions between activated T cells and tumor associated macrophages drive macrophage reprogramming and proinflammatory T cell migration within prostate tumor models.活化的 T 细胞与肿瘤相关巨噬细胞之间的动态相互作用驱动了前列腺肿瘤模型中巨噬细胞的重编程和促炎 T 细胞的迁移。
Sci Rep. 2024 Oct 16;14(1):24230. doi: 10.1038/s41598-024-75265-9.
2
Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization.前列腺癌诱导的内皮细胞向成骨细胞转化通过 Wnt 通路诱导的 M2 巨噬细胞极化在骨肿瘤微环境中引起免疫抑制。
Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2402903121. doi: 10.1073/pnas.2402903121. Epub 2024 Aug 5.
3
STC1 encapsulated in small extracellular vesicles from laryngeal squamous cell carcinoma cells induces CD8 T cell dysfunction by reprogramming tumor-associated macrophages into M2-like macrophages.来自喉鳞状细胞癌细胞的小细胞外囊泡中包裹的STC1通过将肿瘤相关巨噬细胞重编程为M2样巨噬细胞来诱导CD8 T细胞功能障碍。
Cancer Immunol Immunother. 2025 Jan 3;74(2):64. doi: 10.1007/s00262-024-03915-y.
4
Oropharyngeal carcinomas induce circulating monocytes to express a TAM-like pro-tumor expression profile that suppresses T-cell proliferation.口咽癌诱导循环单核细胞表达一种类似肿瘤相关巨噬细胞的促肿瘤表达谱,从而抑制T细胞增殖。
Front Immunol. 2025 Mar 19;16:1539780. doi: 10.3389/fimmu.2025.1539780. eCollection 2025.
5
Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors.巨噬细胞与乳腺癌细胞的串扰:肿瘤内的网络联系。
Results Probl Cell Differ. 2024;74:213-238. doi: 10.1007/978-3-031-65944-7_8.
6
Arginase-1-specific T cells target and modulate tumor-associated macrophages.精氨酸酶-1特异性T细胞靶向并调节肿瘤相关巨噬细胞。
J Immunother Cancer. 2025 Jan 29;13(1):e009930. doi: 10.1136/jitc-2024-009930.
7
Single-cell transcriptional atlas of tumor-associated macrophages in breast cancer.乳腺癌肿瘤相关巨噬细胞的单细胞转录组图谱。
Breast Cancer Res. 2024 Sep 4;26(1):129. doi: 10.1186/s13058-024-01887-6.
8
ANKRD22 participates in the proinflammatory activities of macrophages in the colon cancer tumor microenvironment.ANKRD22参与结肠癌肿瘤微环境中巨噬细胞的促炎活动。
Cancer Immunol Immunother. 2025 Feb 1;74(3):86. doi: 10.1007/s00262-024-03930-z.
9
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers.使用谷氨酰胺拮抗剂 JHU083 对肿瘤相关巨噬细胞进行代谢重编程可促进富含髓系的前列腺癌和膀胱癌中的肿瘤免疫。
Cancer Immunol Res. 2024 Jul 2;12(7):854-875. doi: 10.1158/2326-6066.CIR-23-1105.
10
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.双价和三价 T 细胞衔接器在癌症患者样本中耗尽肿瘤相关巨噬细胞。
J Immunother Cancer. 2019 Nov 21;7(1):320. doi: 10.1186/s40425-019-0807-6.

引用本文的文献

1
Transcriptomic Signatures of Monocyte-Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer.单核细胞衍生巨噬细胞的转录组特征与前列腺癌中雄激素受体通路抑制剂的进展相关。
Prostate. 2025 Jul 2. doi: 10.1002/pros.70000.
2
Bibliometric analysis of programmed cell death and immunogenic cell death in hepatocellular carcinoma immunotherapy: global trends and future directions.肝细胞癌免疫治疗中程序性细胞死亡和免疫原性细胞死亡的文献计量分析:全球趋势与未来方向
Discov Oncol. 2025 Jul 1;16(1):1208. doi: 10.1007/s12672-025-02278-9.

本文引用的文献

1
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication.一个靶向自身新抗原的CD4+TCR和一个靶向自身新抗原的CD8+TCR对于肿瘤根除是必不可少且足够的。
Clin Cancer Res. 2024 Apr 15;30(8):1642-1654. doi: 10.1158/1078-0432.CCR-23-2905.
2
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses.通过整合单细胞和空间转录组分析来剖析免疫抑制性的人类前列腺肿瘤微环境。
Nat Commun. 2023 Feb 7;14(1):663. doi: 10.1038/s41467-023-36325-2.
3
Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform.
基于可重构微流控细胞培养平台的肿瘤微环境综合分析。
FASEB J. 2022 Oct;36(10):e22540. doi: 10.1096/fj.202200684RR.
4
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling.原发前列腺癌类器官的活细胞分子分析鉴定出持续的雄激素受体信号。
Med Oncol. 2021 Sep 28;38(11):135. doi: 10.1007/s12032-021-01582-y.
5
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.如何提高转移性前列腺癌的冷免疫微环境的温度。
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):697-717. doi: 10.1038/s41391-021-00340-5. Epub 2021 Apr 5.
6
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial.纳武利尤单抗联合伊匹单抗治疗转移性去势抵抗性前列腺癌:CheckMate 650 试验中患者的初步分析。
Cancer Cell. 2020 Oct 12;38(4):489-499.e3. doi: 10.1016/j.ccell.2020.08.007. Epub 2020 Sep 10.
7
Immunotherapy in Prostate Cancer.前列腺癌的免疫疗法
Cancers (Basel). 2020 Jul 1;12(7):1752. doi: 10.3390/cancers12071752.
8
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.帕博利珠单抗治疗难治性转移性去势抵抗性前列腺癌:多队列、开放标签的 KEYNOTE-199 研究。
J Clin Oncol. 2020 Feb 10;38(5):395-405. doi: 10.1200/JCO.19.01638. Epub 2019 Nov 27.
9
Reconfigurable open microfluidics for studying the spatiotemporal dynamics of paracrine signalling.可重构开放式微流控技术用于研究旁分泌信号的时空动力学。
Nat Biomed Eng. 2019 Oct;3(10):830-841. doi: 10.1038/s41551-019-0421-4. Epub 2019 Aug 19.
10
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.无症状或轻度症状转移性去势抵抗性前列腺癌的 PROSTVAC III 期临床试验。
J Clin Oncol. 2019 May 1;37(13):1051-1061. doi: 10.1200/JCO.18.02031. Epub 2019 Feb 28.